Terms: = Bone cancer AND EML4, ENSG00000143924, 27436 AND Clinical Outcome
1 results:
1. Combined point mutation in KRAS or EGFR genes and eml4-ALK translocation in lung cancer patients.
Jürgens J; Engel-Riedel W; Prickartz A; Ludwig C; Schildgen O; Tillmann RL; Stoelben E; Brockmann M; Schildgen V
Future Oncol; 2014 Mar; 10(4):529-32. PubMed ID: 24754584
[TBL] [Abstract] [Full Text] [Related]
